Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
Acquisition
|
Turnaround Potential
1303.1000
-1.10
(
-0.08
%)
NSE
Sep 11, 2025
15:31 PM
27.75% Gain from 52W Low
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
09 May 2024
Acquisition
1303.10
-0.08%
Dr Reddy's Labs (HOLD): Driven by North America; India continues to underperform
Hold:
Dr. Reddy's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 5900
BOB Capital Markets Ltd.
DRRD reported largely in-line revenue/EBITDA, but higher tax aided in PAT beat
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch |
11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline |
11 Sep 2025, 03:50PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021